NIH Reporter #5R01AI184293-03

NIAID Grant Solicitation for HIV-1 Cap Epigenetic Modification Research

This opportunity is a research grant solicitation from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, focused on HIV-1 cap epigenetic modification research. - Government Buyer: - National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health - Products/Services Requested: - Research proposals investigating the structural basis of HIV-1 cap hypermethylation - Studies on the impact of cap modifications on viral gene expression and immune signaling - OEMs and Vendors: - No specific OEMs or vendors are named in the solicitation - Unique/Notable Requirements: - Emphasis on advanced biomedical research in immunology and virology - Focus on HIV-1 and epigenetic mechanisms - Open to research organizations, with primary location in Minneapolis, Minnesota - Estimated grant value: $745,891 - No specific product or service line items are listed

Description

This is a research grant opportunity focused on epigenetic modifications related to HIV-1. The project aims to understand the structural basis of HIV cap hypermethylation and its role in viral gene expression and immune signaling. The award is funded by the National Institute of Allergy and Infectious Diseases (NIAID) with a total amount of $745,891 for the fiscal year 2026. The project duration is from August 14, 2024, to June 30, 2029.

View original listing